ORYZON Announces Topline Results from Phase IIb PORTICO
Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary of the data to be presented at the 7th...
Source: globenewswire.com
Oryzon Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oryzon Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oryzon Genomics Today - Breaking & Trending Today
ORYZON Announces a New Financing Through a Convertible Bond
Funding provided by Nice & Green SA, a Swiss private investor This CB Program supersedes the previous oneTo extend its cash runway and continue the...
Source: globenewswire.com
ORYZON to provide corporate progress updates at several events in november
Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13 at at Old Billingsgate in London (UK). Click on link for more info about the LSX Investival Showcase 2023
Source: asebio.com
SPEAR Investments I B : QEV Technologies and SPEAR Investments confirm expected business combination and listing on Euronext Amsterdam
QEV Technologies and SPEAR Investments confirm expected business combination and listing on Euronext Amsterdam QEV Technologies is a fast-growing...
Source: marketscreener.com
ORYZON announces positive results from planned interim analysis of PORTICO, a Phase 2b adaptive trial in Borderline Personality Disorder
Based on interim efficacy and safety data, Independent Data Monitoring Committee recommends continuation of the trial
Source: asebio.com